DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines

BACKGROUND: Platinum compounds are the mainstay of chemotherapy for lung cancer. Unfortunately treatment failure remains a critical issue since about 60 % of all non-small cell lung cancer (NSCLC) patients display intrinsic platinum resistance. METHODS: We analyzed global gene expression profiles of...

Descripción completa

Detalles Bibliográficos
Autores principales: Salim, Hogir, Zong, Dali, Hååg, Petra, Novak, Metka, Mörk, Birgitta, Lewensohn, Rolf, Lundholm, Lovisa, Viktorsson, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565013/
https://www.ncbi.nlm.nih.gov/pubmed/26353782
http://dx.doi.org/10.1186/s12885-015-1635-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565013/
https://www.ncbi.nlm.nih.gov/pubmed/26353782
http://dx.doi.org/10.1186/s12885-015-1635-9

Ejemplares similares